Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy.

导出 OA

翻译打印收藏纠错

作者： Dong Geon,Kim ^[1] ; Kang Ho,Kim ^[2] ; Yun Jee,Seo ^[2] ; Heekyoung,Yang ^[3] ; Eric G,Marcusson ^[4] ; Eunju,Son ^[5] ; Kyoungmin,Lee ^[1] ; Jason K,Sa ^[1] ; Hye Won,Lee ^[6] ; Do-Hyun,Nam ^[7]

作者单位： Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.;Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea. ^[1] Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea. ^[2] Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.;Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[3] Providence Therapeutics, Calgary, Canada. ^[4] Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.;Department of Anatomy and Cell Biology, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[5] Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.;Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.;Department of Urology, Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Korea. ^[6] Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, Korea.;Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea.;Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. ^[7]

关键词 anti-miR delivery efficiency glioblastoma intratumoral injection intraventricular injection